The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

Corrigall, William A., Franklin, Keith B. J., Coen, Kathleen M., Clarke, Paul B. S.·1992·Psychopharmacology

Cited by (833)

Items 201–300 of 833

  1. Bupropion Inhibits Nicotine-Evoked [3H]Overflow from Rat Striatal Slices Preloaded with [3H]Dopamine and from Rat Hippocampal Slices Preloaded with [3H]Norepinephrine
    Dennis K. Miller, Sangeetha P. Sumithran, Linda P. Dwoskin · 2002 · Journal of Pharmacology and Experimental Therapeutics
  2. The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery
    Roger L. Papke, Linda P. Dwoskin, Peter Anthony Crooks · 2007 · Journal of Neurochemistry
  3. Alteration of the Behavioral Effects of Nicotine by Chronic Caffeine Exposure
    Gianluigi Tanda, Steven R. Goldberg · 2000 · Pharmacology Biochemistry and Behavior
  4. A psychobiological framework of the substrates that mediate nicotine use during adolescence
    O'Dell, Laura E. · 2009 · Neuropharmacology
  5. Effects of Intravenous Cocaine and Cigarette Smoking on Luteinizing Hormone, Testosterone, and Prolactin in Men
    Mendelson, Jack H., Sholar, Michelle B., Mutschler, Nicole H., Jaszyna-Gasior, Maria, Goletiani, Nathalie V., Siegel, Arthur J., Mello, Nancy K. · 2003 · The Journal of Pharmacology and Experimental Therapeutics
  6. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development
    Sanna K. Janhunen, Liisa Ahtee · 2006 · Neuroscience & Biobehavioral Reviews
  7. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report
    David J.K. Balfour · 2000 · European Heart Journal
  8. Active Immunization against Nicotine Suppresses Nicotine-Induced Dopamine Release in the Rat Nucleus accumbens Shell
    S.H.L. de Villiers, Nina Lindblom, Genadiy Kalayanov, Sandra Leigh Gordon, Anna Malmerfelt, Anette M. Johansson, Torgny H. Svensson · 2002 · Respiration
  9. Nicotine-Induced Enhancement of Glutamatergic and GABAergic Synaptic Transmission in the Mouse Amygdala
    Nobl Barazangi, Lorna W. Role · 2001 · Journal of Neurophysiology
  10. Nicotinic acetylcholine receptors: an overview on drug discovery
    Dieter D’hoedt, Daniel Bertrand · 2009 · Expert Opinion on Therapeutic Targets
  11. The Reinforcing Properties of Nicotine are Associated with a Specific Patterning of c‐fos Expression in the Rat Brain
    Sonia R. Pagliusi, Michela Tessari, S DEVEVEY, Christian Chiamulera, Emilio Merlo Pich · 1996 · European Journal of Neuroscience
  12. Nicotine administration stimulates the in vivo N‐methyl‐ D ‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release
    Ernesto Fedele, Giorgia Varnier, Maria Antonia Ansaldo, Maurizio Raiteri · 1998 · British Journal of Pharmacology
  13. Blockade of nicotinic receptor‐mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administeredin vitro
    Hiba El-Bizri, Paul B. S. Clarke · 1994 · British Journal of Pharmacology
  14. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats
    Mark G. LeSage, David Shelley, Jason T. Ross, Frank Ivy Carroll, William A. Corrigall · 2008 · Pharmacology Biochemistry and Behavior
  15. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats
    Manon St. Louis, Paul B. S. Clarke · 1998 · Neuropharmacology
  16. Smoking Cessation and Chronic Pain: Patient and Pain Medicine Physician Attitudes
    William Michael Hooten, Kristin S. Vickers, Yu Shi, Kaye L. Ebnet, Cynthia Oswald Townsend, Christi A. Patten, David O. Warner · 2011 · Pain Practice
  17. Selective stimulation of serotonin2Creceptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration
    Vincenzo Di Matteo, Massimo Pierucci, Ennio Esposito · 2004 · Journal of Neurochemistry
  18. Analgesia and Abuse Potential: An Accidental Association or a Common Substrate?
    Keith B.J. Franklin · 1998 · Pharmacology Biochemistry and Behavior
  19. Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens
    Laurie H. L. Sellings, Golriz. Baharnouri, Lindsey E. McQuade, Paul B. S. Clarke · 2008 · European Journal of Neuroscience
  20. Recognising Nicotine: The Neurobiological Basis of Nicotine Discrimination
    Janice W. Smith, Ian P. Stolerman · 2009 · Handbook of experimental pharmacology
  21. Nicotine Vaccines to Assist with Smoking Cessation
    Tobias Raupach, Philippe Hoogsteder, Onno C. P. van Schayck · 2012 · Drugs
  22. A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females
    Laura E. O’Dell, Oscar V. Torres · 2013 · Neuropharmacology
  23. Tobacco use as a predictor of illicit drug use and drug-related problems in Colombian youth
    L SIQUEIRA, Judith S. Brook · 2002 · Journal of Adolescent Health
  24. Investigations using immunization to attenuate the psychoactive effects of nicotine
    M.Rocı́o A Carrera, Jon A. Ashley, Timothy Z. Hoffman, Shigeki Isomura, Peter Wirsching, George F. Koob, Kim D. Janda · 2003 · Bioorganic & Medicinal Chemistry
  25. Biological basis of tobacco addiction: Implications for smoking-cessation treatment
    Ram Chander Jiloha · 2010 · Indian Journal of Psychiatry
  26. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence
    Jennie Z. Ma, Joke Beuten, Thomas J. Payne, Randolph T. Dupont, Robert C. Elston, Ming D. Li · 2005 · Human Molecular Genetics
  27. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice
    Camron D. Bryant, Shoshana Eitan, Kevin Sinchak, Michael S. Fanselow, Christopher J. Evans · 2006 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  28. Brain-Stimulation Reward Thresholds Raised by an Antisense Oligonucleotide for the M5 Muscarinic Receptor Infused near Dopamine Cells
    John S. Yeomans, Junichi Takeuchi, Marco A. S. Baptista, Donna D. Flynn, Karen Lepik, José N. Nóbrega, James Fulton, Martin Roland Ralph · 2000 · Journal of Neuroscience
  29. Rats Self-Administer Intravenous Nicotine Delivered in a Novel Smoking-Relevant Procedure: Effects of Dopamine Antagonists
    Robert E. Sorge, Paul B. S. Clarke · 2009 · Journal of Pharmacology and Experimental Therapeutics
  30. Varenicline Is a Potent Partial Agonist at α6β2* Nicotinic Acetylcholine Receptors in Rat and Monkey Striatum
    Bordia, Tanuja, Hrachova, Maya, Chin, Matthew, McIntosh, J. Michael, Quik, Maryka · 2012 · The Journal of Pharmacology and Experimental Therapeutics
  31. Dynamic increases in dopamine during paced copulation in the female rat
    William J. Jenkins, Jill B. Becker · 2003 · European Journal of Neuroscience
  32. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement
    Paul J. Fletcher, Zoë Rizos, Kevin Noble, Ashlie D. Soko, Leo B. Silenieks, Anh Dzung Lê, Guy A. Higgins · 2012 · Neuropharmacology
  33. Lobeline inhibits nicotine-evoked [3H]dopamine overflow from rat striatal slices and nicotine-evoked 86Rb+ efflux from thalamic synaptosomes
    Dennis K. Miller, Peter Anthony Crooks, Linda P. Dwoskin · 2000 · Neuropharmacology
  34. Tobacco dependence, the insular cortex and the hypocretin connection
    Kenny, Paul J. · 2011 · Pharmacology Biochemistry and Behavior
  35. Topiramate selectively attenuates nicotine-induced increases in monoamine release
    Schiffer, Wynne K., Gerasimov, Madina R., Marsteller, Douglas A., Geiger, Justin, Barnett, Channing, Alexoff, David L., Dewey, Stephen L. · 2001 · Synapse
  36. Effects of Smoking Successive Low- and High-Nicotine Cigarettes on Hypothalamic–Pituitary–Adrenal Axis Hormones and Mood in Men
    Jack H. Mendelson, Nathalie V. Goletiani, Michelle B. Sholar, Arthur J. Siegel, Nancy K. Mello · 2007 · Neuropsychopharmacology
  37. Involvement of serotonin in nicotine dependence: Processes relevant to positive and negative regulation of drug intake
    Peter Olausson, Jörgen A. Engel, Bo Söderpalm · 2002 · Pharmacology Biochemistry and Behavior
  38. Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain
    Paul D. Cumming, Pedro Rosa‐Neto, Hideaki Watanabe, Donald Frederick Smith, Dirk Bender, Paul B. S. Clarke, ALBERT H. GJEDDE · 2003 · NeuroImage
  39. Acute and chronic effects of nornicotine on locomotor activity in rats: altered response to nicotine
    Linda P. Dwoskin, Peter Anthony Crooks, Lihong Teng, Thomas A. Green, Michael Thomas Bardo · 1999 · Psychopharmacology
  40. Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon
    Musachio, John L., Villemagne, Victor L., Scheffel, Ursula A., Dannals, Robert F., Dogan, A.Semih, Yokoi, Fuji, Wong, Dean F. · 1999 · Nuclear Medicine and Biology
  41. Blockade of Dopamine D4 Receptors Attenuates Reinstatement of Extinguished Nicotine-Seeking Behavior in Rats
    Yijin Yan, Abhiram P. Pushparaj, Yann Le Strat, Islam Gamaleddin, Chanel Barnes, Zuzana Justinová, Steven R. Goldberg, Bernard Le Foll · 2011 · Neuropsychopharmacology
  42. Rats prefer cocaine over nicotine in a two-lever self-administration choice test
    Ann M. Manzardo, Larry Stein, J. D. Belluzzi · 2002 · Brain Research
  43. Reinstatement of nicotine-conditioned place preference by drug priming: Effects of calcium channel antagonists
    Grażyna Biała, Barbara Budzyńska · 2006 · European Journal of Pharmacology
  44. Reboxetine: Attenuation of Intravenous Nicotine Self-Administration in Rats
    Anthony S. Rauhut, Stephanie N. Mullins‐Sweatt, Linda P. Dwoskin, Michael Thomas Bardo · 2002 · Journal of Pharmacology and Experimental Therapeutics
  45. Neural activity related to the processing of increasing monetary reward in smokers and nonsmokers
    Chantal Martin-Söelch, John H. Missimer, Klaus Leonhard Leenders, W Schultz · 2003 · European Journal of Neuroscience
  46. From smoking to lung cancer: the CHRNA5/A3/B4 connection
    Ma. Reina Improgo, Michael D. Scofield, Andrew R. Tapper, Paul D Gardner · 2010 · Oncogene
  47. Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
    Bernard Le Foll, Patricia Di Ciano, Leigh V. Panlilio, Steven R. Goldberg, Roberto Ciccocioppo · 2013 · Current Drug Targets
  48. The effect of nicotine on developing brain catecholamine systems
    Schatten Heather · 1999 · Frontiers in bioscience
  49. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine
    Maureen E.M. Benwell, David J.K. Balfour, Heidi M. Lucchi · 1993 · Psychopharmacology
  50. Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
    Paul Whiteaker, H. S. Garcha, Susan Wonnacott, Ian P. Stolerman · 1995 · British Journal of Pharmacology
  51. The Neurobiology of Tobacco Dependence: A Commentary
    David J.K. Balfour · 2002 · Respiration
  52. Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats
    Karine Guillem, Caroline Vouillac‐Mendoza, Marc R. Azar, Loren H. Parsons, George F. Koob, Martine Cador, Luis Stinus · 2006 · European Journal of Neuroscience
  53. Periadolescent Nicotine Exposure Reduces Cocaine Reward in Adult Mice
    Brian M. Kelley, Lawrence D. Middaugh · 1999 · Journal of Addictive Diseases
  54. Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
    Enrique L. M. Ochoa, Jose Antonio Lasalde‐Dominicci · 2007 · Cellular and Molecular Neurobiology
  55. The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion
    Paul B. S. Clarke, Isabelle Chaudieu, Hiba El-Bizri, Patricia Boksa, Maryka Quik, Barbara A. Esplin, R. Čapek · 1994 · British Journal of Pharmacology
  56. Acute nicotine induces anxiety and disrupts temporal pattern organization of rat exploratory behavior in hole-board: a potential role for the lateral habenula
    Maurizio Casarrubea, Caitlin Davies, Fabiana Faulisi, Massimo Pierucci, Roberto Colangeli, Lucy Partridge, Stephanie Chambers, Daniel Cassar, Mario Valentino, Richard Muscat et al. · 2015 · Frontiers in Cellular Neuroscience
  57. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA
    Abdulghani A. Houdi, Romi Dasgupta, Mark S. Kindy · 1998 · Brain Research
  58. Nicotine addiction: insights from recent animal studies
    Anne-Marie Mathieu-Kia, Scott H. Kellogg, Eduardo R. Butelman, Mary Jeanne Kreek · 2002 · Psychopharmacology
  59. Age dependent nicotinic influences over dopamine neuron synaptic plasticity
    Placzek, Andon N., Zhang, Tao A., Dani, John A. · 2009 · Biochemical Pharmacology
  60. Effects of dopamine antagonists on drug cue-induced reinstatement of nicotine-seeking behavior in rats
    Xiu Liu, Courtney Jernigen, Maysa A. Gharib, Sheri Booth, Anthony R. Caggiula, Alan F. Sved · 2010 · Behavioural Pharmacology
  61. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats
    Grażyna Biała, Natasza Staniak, Barbara Budzyńska · 2010 · Naunyn-Schmiedeberg s Archives of Pharmacology
  62. Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats
    Jason T. Ross, William A. Corrigall, Christian A. Heidbreder, Mark G. LeSage · 2007 · European Journal of Pharmacology
  63. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents.
    Grażyna Biała · 2003 · PubMed
  64. Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia
    Gabriela Novak, Martha LeBlanc, Clement C.H. Zai, Sajid Ali Shaikh, Julien Renou, Vincenzo De Luca, Natalie Bulgin, James L. Kennedy, Bernard Le Foll · 2010 · Annals of Human Genetics
  65. Historical and current perspective on tobacco use and nicotine addiction
    John A. Dani, David J.K. Balfour · 2011 · Trends in Neurosciences
  66. Reboxetine: Functional Inhibition of Monoamine Transporters and Nicotinic Acetylcholine Receptors
    Dennis K. Miller, Erik H.F. Wong, M.Dathan Chesnut, Linda P. Dwoskin · 2002 · Journal of Pharmacology and Experimental Therapeutics
  67. Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice
    Helena Gäddnäs, Kirsi Pietilä, Liisa Ahtee · 2000 · Behavioural Brain Research
  68. Long-term, low-level adolescent nicotine exposure produces dose-dependent changes in cocaine sensitivity and reward in adult mice
    Kelley, Brian M., Rowan, James D. · 2004 · International Journal of Developmental Neuroscience
  69. Effects of Nicotine and Mecamylamine Microinjections into the Nucleus Accumbens on Ethanol and Sucrose Self-Administration
    Roser A. Nadal, Ann M. Chappell, H. H. Samson · 1998 · Alcoholism Clinical and Experimental Research
  70. Consenso sobre o tratamento da dependência de nicotina
    Ana Cecília Petta Roselli Marques, Angelo Campana, Analice de Paula Gigliotti, Maria Teresa Cruz Lourenço, Montezuma Pimenta Ferreira, Ronaldo Laranjeira · 2001 · Brazilian Journal of Psychiatry
  71. Tobacco Smoking and Nicotine Neuropsychopharmacology: Some Future Research Directions
    Edward F. Domino · 1998 · Neuropsychopharmacology
  72. In vivo imaging of nicotinic receptor upregulation following chronic (−)-nicotine treatment in baboon using SPECT
    Kassiou, Michael, Eberl, Stefan, Meikle, Steven R, Birrell, Alex, Constable, Chris, Fulham, Michael J, Wong, Dean F, Musachio, John L · 2001 · Nuclear Medicine and Biology
  73. Nicotinic receptor modulation to treat alcohol and drug dependence
    Shafiqur Rahman, Eric A. Engleman, Richard L. Bell · 2015 · Frontiers in Neuroscience
  74. Role of the endogenous cannabinoid system in nicotine addiction: novel insights
    Islam Gamaleddin · 2015 · Frontiers in Psychiatry
  75. Receptor systems participating in nicotine-specific effects
    Istvan Sziráki, Henry W. Sershen, Myron Benuck, Audrey Hashim, Ábel Lajtha · 1998 · Neurochemistry International
  76. 5-[I- ]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors
    Musachio, John L., Scheffel, Ursula, Finley, Paige A., Zhan, Yougen, Mochizuki, Takao, Wagner, Henry N., Dannals, Robert F. · 1998 · Life Sciences
  77. Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers
    Brett Froeliger, David G. Gilbert, Francis Joseph McClernon · 2009 · Psychopharmacology
  78. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives
    María Scherma, Anna Lisa Muntoni, Miriam Melis, Liana Fattore, Paola Fadda, Walter Fratta, Marco Pistis · 2016 · Psychopharmacology
  79. Conditioned Place Preference Induced by Licit Drugs: Establishment, Extinction, and Reinstatement
    Yu Liu, Bernard Le Foll, Yanli Liu, X. L. Wang, Lin Lü · 2008 · The Scientific World JOURNAL
  80. A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics
    Ric M. Procyshyn, N. Ihsan, D. Thompson · 2001 · International Clinical Psychopharmacology
  81. Intravenous self‐administration of nicotine is altered by lesions of the posterior, but not anterior, pedunculopontine tegmental nucleus
    Helen L. Alderson, Mary P. Latimer, Philip Winn · 2006 · European Journal of Neuroscience
  82. Nicotinic receptor-based therapeutics and candidates for smoking cessation
    Linda P. Dwoskin, Andrew M. Smith, Thomas E. Wooters, Zhenfa Zhang, Peter Anthony Crooks, Michael Thomas Bardo · 2009 · Biochemical Pharmacology
  83. The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response
    Mohammad‐Reza Zarrindast, Nima Naghdi-Sedeh, Mohammad Nasehi, Hedayat Sahraei, Farideh Bahrami, Fereshteh Asadi · 2010 · Neuroscience Letters
  84. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice
    Eylem Celik, Tayfun I. Uzbay, Sirel Karakaş · 2005 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  85. Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex
    Lisa S. Middleton, Wayne A. Cass, Linda P. Dwoskin · 2004 · Journal of Pharmacology and Experimental Therapeutics
  86. Endocrine effects of nicotine administration, tobacco and other drug withdrawal in humans
    Wallace B. Pickworth, Reginald V. Fant · 1998 · Psychoneuroendocrinology
  87. Nicotine modifies the activity of ventral tegmental area dopaminergic neurons and hippocampal GABAergic neurons
    Janet L. Fisher, Volodymyr I. Pidoplichko, John A. Dani · 1998 · Journal of Physiology-Paris
  88. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
    Lisa M. Marubio, Jean‐Pierre Changeux · 2000 · European Journal of Pharmacology
  89. Lack of effect of acute dopamine precursor depletion in nicotine-dependent smokers
    Casey, Kevin F., Benkelfat, Chawki, Young, Simon N., Leyton, Marco · 2006 · European Neuropsychopharmacology
  90. A DRD2 and ANKK1 haplotype is associated with nicotine dependence
    Joanne Voisey, Christopher Dean Swagell, Ian Paul Hughes, Angela van Daal, Ernest Pascal Noble, Bruce R. Lawford, Ross McD. Young, Charles Phillip Morris · 2012 · Psychiatry Research
  91. Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
    Peter Anthony Crooks, Michael Thomas Bardo, Linda P. Dwoskin · 2014 · Advances in pharmacology
  92. Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes
    Lisa Hartman Brauer, Matthew Cramblett, Debra A. Paxton, Jed E. Rose · 2001 · Psychopharmacology
  93. Chronic Nicotine Enhances Basal and Nicotine-Induced Fos Immunoreactivity Preferentially in the Medial Prefrontal Cortex of the Rat
    Margret Nisell · 1997 · Neuropsychopharmacology
  94. Potential pathways of pesticide action on erectile function – A contributory factor in male infertility
    R.P. Kaur, V. Gupta, Ajay Francis Christopher, P. Bansal · 2015 · Asian Pacific Journal of Reproduction
  95. Neurophysiology of Nicotine Addiction
    John A. Dani, Daniel Jenson, John I. Broussard · 2012 · Journal of Addiction Research & Therapy
  96. Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI
    Deborah W. Tang, Brian Hello, Margaret Mroziewicz, Lesley K. Fellows, Rachel Fynvola Tyndale, Alain Dagher · 2012 · NeuroImage
  97. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice
    M. Cristina Martellotta, Alexander V. Kuzmin, Edwin E. Zvartau, G Cossu, Gian Luigi Gessa, Walter Fratta · 1995 · Pharmacology Biochemistry and Behavior
  98. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
    Olivier George, Allison Lloyd, Frank Ivy Carroll, Mohamad Imad Damaj, George F. Koob · 2010 · Psychopharmacology
  99. Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonists ICS 205–930 and MDL 72222
    William A. Corrigall, Kathleen M. Coen · 1994 · Pharmacology Biochemistry and Behavior
  100. Object preference and nicotine consumption in rats with high vs. low rearing activity in a novel open field
    Cornelius Rainer Pawlak · 2002 · Pharmacology Biochemistry and Behavior